These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28038919)

  • 21. Do people have differing motivations for participating in a stated-preference study? Results from a latent-class analysis.
    Hollin IL; Janssen E; Kelley MA; Bridges JFP
    BMC Med Inform Decis Mak; 2021 Feb; 21(1):44. PubMed ID: 33549068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of concordance between subjective improvement and symptom change in psychotic episodes.
    Kupper Z; Tschacher W
    Br J Clin Psychol; 2008 Mar; 47(Pt 1):75-93. PubMed ID: 17927846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Housing for persons with serious mental illness: consumer and service provider preferences.
    Piat M; Lesage A; Boyer R; Dorvil H; Couture A; Grenier G; Bloom D
    Psychiatr Serv; 2008 Sep; 59(9):1011-7. PubMed ID: 18757594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.
    Hofheinz R; Clouth J; Borchardt-Wagner J; Wagner U; Weidling E; Jen MH; Brück P
    BMC Cancer; 2016 Dec; 16(1):937. PubMed ID: 27923357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The child and adolescent first-episode psychosis study (CAFEPS): design and baseline results.
    Castro-Fornieles J; Parellada M; Gonzalez-Pinto A; Moreno D; Graell M; Baeza I; Otero S; Soutullo CA; Crespo-Facorro B; Ruiz-Sancho A; Desco M; Rojas-Corrales O; Patiño A; Carrasco-Marin E; Arango C;
    Schizophr Res; 2007 Mar; 91(1-3):226-37. PubMed ID: 17267179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferences for treatment during a first psychotic episode.
    de Haan L; van Raaij B; van den Berg R; Jager M; Houweling P; Stockmann M; Delsing P; Linszen D; Peters B; Wouters L
    Eur Psychiatry; 2001 Mar; 16(2):83-9. PubMed ID: 11311171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician and Patient Preferences for Nonvalvular Atrial Fibrillation Therapies.
    Shafrin J; Bruno A; MacEwan JP; Campinha-Bacote A; Trocio J; Shah M; Tan W; Romley JA
    Value Health; 2016 Jun; 19(4):451-9. PubMed ID: 27325337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint Study.
    Smith SM; Gewandter JS; Kitt RA; Markman JD; Vaughan JA; Cowan P; Kopecky EA; Malamut R; Sadosky A; Tive L; Turk DC; Dworkin RH
    J Pain; 2016 Nov; 17(11):1198-1206. PubMed ID: 27555429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying potential predictors of traumatic reactions to psychotic episodes.
    Chisholm B; Freeman D; Cooke A
    Br J Clin Psychol; 2006 Nov; 45(Pt 4):545-59. PubMed ID: 17076963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using conjoint analysis to model the preferences of different patient segments for attributes of patient-centered care.
    Cunningham CE; Deal K; Rimas H; Campbell H; Russell A; Henderson J; Matheson A; Melnick B
    Patient; 2008 Dec; 1(4):317-30. PubMed ID: 22272999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories.
    Iyer SN; Boekestyn L; Cassidy CM; King S; Joober R; Malla AK
    Psychol Med; 2008 Aug; 38(8):1147-56. PubMed ID: 18366823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
    Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
    J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment.
    van den Wijngaard L; Rodijk IC; van der Veen F; Gooskens-van Erven MH; Koks CA; Verhoeve HR; Mol BW; van Wely M; Mochtar MH
    Hum Reprod; 2015 Feb; 30(2):331-7. PubMed ID: 25432926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing adolescent preference in the treatment of first-episode psychosis and psychosis risk.
    Welsh P; Tiffin PA
    Early Interv Psychiatry; 2014 Aug; 8(3):281-5. PubMed ID: 23870289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating consumers' and informal carers' views and preferences for consumer directed care: A discrete choice experiment.
    Kaambwa B; Lancsar E; McCaffrey N; Chen G; Gill L; Cameron ID; Crotty M; Ratcliffe J
    Soc Sci Med; 2015 Sep; 140():81-94. PubMed ID: 26210656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A discrete choice experiment to assess people living with HIV's (PLWHIV's) preferences for GP or HIV clinic appointments.
    Miners AH; Llewellyn CD; Cooper VL; Youssef E; Pollard AJ; Lagarde M; Sabin C; Nixon E; Sachikonye M; Perry N; Fisher M
    Sex Transm Infect; 2017 Mar; 93(2):105-111. PubMed ID: 27535762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up after treatment for breast cancer: one strategy fits all? An investigation of patient preferences using a discrete choice experiment.
    Kimman ML; Dellaert BG; Boersma LJ; Lambin P; Dirksen CD
    Acta Oncol; 2010 Apr; 49(3):328-37. PubMed ID: 20148645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
    Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
    Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.
    Benning TM; Dellaert BG; Severens JL; Dirksen CD
    Value Health; 2014 Jul; 17(5):578-87. PubMed ID: 25128051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.